Lcn2 (lipocalin 2) - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: Lcn2 (lipocalin 2) Rattus norvegicus
Analyze
Symbol: Lcn2
Name: lipocalin 2
RGD ID: 69408
Description: Enables enterobactin binding activity; identical protein binding activity; and protease binding activity. Involved in several processes, including cellular response to cytokine stimulus; memory; and regulation of neuron apoptotic process. Located in cytosol and extracellular space. Used to study intrahepatic cholangiocarcinoma and retinal degeneration. Biomarker of several diseases, including acute kidney failure; congenital diaphragmatic hernia; obesity; pulmonary hypertension; and transient cerebral ischemia. Human ortholog(s) of this gene implicated in urinary tract infection. Orthologous to human LCN2 (lipocalin 2); INTERACTS WITH (+)-schisandrin B; (-)-citrinin; 1-naphthyl isothiocyanate.
Type: protein-coding
RefSeq Status: PROVISIONAL
Previously known as: alpha-2-microglobulin-related protein; alpha-2U globulin-related protein; lipocalin 2 (oncogene 24p3); lipocalin 24p3; lipocalin-2; neutrophil gelatinase-associated lipocalin; NGAL; p25; siderocalin LCN2; Sip24
RGD Orthologs
Human
Mouse
Bonobo
Dog
Squirrel
Pig
Green Monkey
Alliance Genes
More Info more info ...
Latest Assembly: mRatBN7.2 - mRatBN7.2 Assembly
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
mRatBN7.2315,680,688 - 15,684,033 (-)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl315,680,687 - 15,684,095 (-)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx318,749,510 - 18,752,856 (-)NCBIRnor_SHR
UTH_Rnor_SHRSP_BbbUtx_1.0327,334,505 - 27,337,851 (-)NCBIRnor_SHRSP
UTH_Rnor_WKY_Bbb_1.0325,585,359 - 25,588,705 (-)NCBIRnor_WKY
Rnor_6.0311,414,189 - 11,417,534 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl311,414,186 - 11,417,546 (-)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.0316,763,059 - 16,766,404 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.4311,511,402 - 11,514,747 (-)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.1311,407,773 - 11,411,119 (-)NCBI
Celera310,423,569 - 10,426,914 (-)NCBICelera
Cytogenetic Map3p12NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Disease Annotations     Click to see Annotation Detail View
Abscess  (IEP)
acute cystitis  (ISO)
acute kidney failure  (IEP,ISO)
adult respiratory distress syndrome  (ISO)
amyotrophic lateral sclerosis  (IEP)
Animal Hepatitis  (ISO)
autosomal dominant polycystic kidney disease  (ISO)
beta thalassemia  (ISO)
calcinosis  (ISO)
celiac disease  (ISO)
Cerebral Hemorrhage  (IEP)
Chemical and Drug Induced Liver Injury  (ISO)
Chlamydophila Infections  (ISO)
chronic kidney disease  (ISO)
colon cancer  (IEP)
congenital diaphragmatic hernia  (IEP,ISO)
congenital disorder of glycosylation Iu  (ISO)
contact dermatitis  (ISO)
Contrast-Induced Nephropathy  (IEP)
COVID-19  (ISO)
developmental and epileptic encephalopathy  (ISO)
developmental and epileptic encephalopathy 31  (ISO)
Diabetic Nephropathies  (IEP,ISO)
disease of cellular proliferation  (ISO)
Drug-Related Side Effects and Adverse Reactions  (ISO)
early infantile epileptic encephalopathy  (ISO)
end stage renal disease  (ISO)
Endotoxemia  (ISO)
Escherichia Coli Infections  (ISO)
essential hypertension  (ISO)
Experimental Diabetes Mellitus  (IEP)
Experimental Liver Cirrhosis  (ISO)
Experimental Radiation Injuries  (IEP)
Haemophilus Infections  (ISO)
heart valve disease  (ISO)
Helicobacter Infections  (ISO)
hidradenitis suppurativa  (ISO)
hydronephrosis  (ISO)
hyperuricemia  (ISO)
IgA glomerulonephritis  (ISO)
Inflammation  (ISO)
intrahepatic cholangiocarcinoma  (IDA,ISO)
kidney disease  (ISO)
Kidney Reperfusion Injury  (IEP,ISO)
Klebsiella pneumonia  (ISO)
myocardial infarction  (ISO)
myocarditis  (IEP)
Neoplasm Metastasis  (ISO)
obesity  (IEP,ISO)
oral candidiasis  (ISO)
pneumonia  (ISO)
polycystic kidney disease  (ISO)
pre-eclampsia  (ISO)
primary coenzyme Q10 deficiency 7  (ISO)
pulmonary hypertension  (IEP,ISO)
pulmonary tuberculosis  (ISO)
renal fibrosis  (ISO)
Renal Ischemia  (ISO)
renovascular hypertension  (ISO)
retinal degeneration  (IDA,IMP)
rheumatoid arthritis  (ISO)
Sepsis  (ISO)
Streptococcal Infections  (ISO)
Stroke  (ISO)
Subarachnoid Hemorrhage  (ISO)
transient cerebral ischemia  (IEP)
Traumatic Brain Injuries  (IEP)
type 2 diabetes mellitus  (ISO)
urinary tract infection  (ISO)
uveitis  (IEP)
West Nile encephalitis  (ISO)

Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
(+)-schisandrin B  (EXP)
(-)-citrinin  (EXP)
1,1-dichloroethene  (ISO)
1-naphthyl isothiocyanate  (EXP,ISO)
11-deoxycorticosterone  (EXP)
17alpha-ethynylestradiol  (ISO)
17beta-estradiol  (EXP,ISO)
17beta-estradiol 3-benzoate  (EXP)
2,2',4,4'-Tetrabromodiphenyl ether  (EXP,ISO)
2,3,7,8-tetrachlorodibenzodioxine  (EXP,ISO)
2,3,7,8-Tetrachlorodibenzofuran  (ISO)
2,4,6-trinitrobenzenesulfonic acid  (ISO)
2,4,6-trinitrotoluene  (EXP)
2-amino-2-deoxy-D-glucopyranose  (ISO)
2-hydroxypropanoic acid  (ISO)
3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine  (EXP)
3,3',4,4',5-pentachlorobiphenyl  (EXP)
3,4-dichloroaniline  (EXP,ISO)
3-chloropropane-1,2-diol  (EXP,ISO)
3-isobutyl-1-methyl-7H-xanthine  (ISO)
4,4'-diaminodiphenylmethane  (EXP)
4,4'-sulfonyldiphenol  (ISO)
4-hydroxyphenyl retinamide  (ISO)
6-propyl-2-thiouracil  (EXP)
8-anilinonaphthalene-1-sulfonic acid  (ISO)
9-cis-retinoic acid  (ISO)
acetylsalicylic acid  (EXP)
Actein  (EXP)
adefovir  (EXP)
adefovir pivoxil  (ISO)
aflatoxin B1  (EXP,ISO)
Aflatoxin B2 alpha  (ISO)
agomelatine  (EXP)
aldehydo-D-glucosamine  (ISO)
all-trans-4-oxoretinoic acid  (ISO)
all-trans-retinoic acid  (ISO)
aluminium oxide  (ISO)
ammonium chloride  (EXP)
amphotericin B methyl ester  (ISO)
anthocyanin  (EXP)
aristolochic acid  (EXP)
arsenous acid  (ISO)
atorvastatin calcium  (EXP,ISO)
bacitracin  (EXP)
benzo[a]pyrene  (ISO)
Benzo[ghi]perylene  (ISO)
beta-D-glucosamine  (ISO)
bicalutamide  (ISO)
bis(2-ethylhexyl) phthalate  (EXP,ISO)
bisphenol A  (EXP,ISO)
bleomycin A2  (ISO)
butanal  (ISO)
Butylbenzyl phthalate  (EXP)
C60 fullerene  (EXP)
cadmium atom  (ISO)
cadmium dichloride  (EXP,ISO)
calcitriol  (ISO)
cannabidiol  (ISO)
carbon nanotube  (EXP,ISO)
carmustine  (EXP,ISO)
cerium trichloride  (ISO)
chlordecone  (ISO)
chloroquine  (EXP)
cholesterol  (ISO)
choline  (ISO)
ciprofibrate  (ISO)
ciprofloxacin  (ISO)
cisplatin  (EXP,ISO)
cobalt dichloride  (ISO)
copper atom  (ISO)
copper(0)  (ISO)
crocidolite asbestos  (ISO)
curcumin  (EXP,ISO)
cyanuric acid  (EXP)
cyclophosphamide  (EXP,ISO)
cyclosporin A  (EXP,ISO)
dapagliflozin  (EXP)
decabromodiphenyl ether  (EXP)
deferasirox  (EXP,ISO)
desferrioxamine B  (ISO)
dexamethasone  (EXP,ISO)
dextran sulfate  (ISO)
diarsenic trioxide  (ISO)
dibutyl phthalate  (EXP)
diclofenac  (EXP,ISO)
dieldrin  (EXP)
diethyl phthalate  (EXP)
diethylstilbestrol  (EXP,ISO)
diisobutyl phthalate  (EXP)
diisononyl phthalate  (EXP)
dioxygen  (EXP,ISO)
diuron  (EXP)
doxorubicin  (EXP,ISO)
doxycycline  (ISO)
enilconazole  (ISO)
epoxiconazole  (ISO)
ethanol  (EXP,ISO)
etoposide  (EXP)
fenvalerate  (EXP)
ferric ammonium citrate  (ISO)
ferrostatin-1  (ISO)
fluconazole  (EXP)
folic acid  (ISO)
fragrance  (ISO)
fructose  (EXP)
furan  (ISO)
gefitinib  (ISO)
gemfibrozil  (ISO)
genistein  (ISO)
gentamycin  (EXP,ISO)
glafenine  (EXP)
glycidol  (ISO)
graphene oxide  (ISO)
graphite  (EXP)
Hexachloro-1,3-butadiene  (EXP)
hexachlorobenzene  (EXP)
hydroquinone  (ISO)
iomeprol  (EXP)
iron atom  (ISO)
iron(0)  (ISO)
isocyanuric acid  (EXP)
isoniazide  (EXP)
isoprenaline  (ISO)
isotretinoin  (ISO)
ketamine  (ISO)
ketoconazole  (EXP)
L-methionine  (ISO)
lead diacetate  (EXP)
lead(0)  (ISO)
lead(2+)  (ISO)
lipopolysaccharide  (ISO)
lovastatin  (ISO)
maleic acid  (EXP)
Mecamylamine  (ISO)
medroxyprogesterone acetate  (ISO)
melamine  (EXP)
mercury atom  (EXP)
mercury dichloride  (EXP,ISO)
mercury(0)  (EXP)
metformin  (EXP)
methimazole  (EXP)
methotrexate  (EXP)
methoxychlor  (EXP)
methylmercury chloride  (EXP,ISO)
microcystin-LR  (ISO)
morphine  (ISO)
Muraglitazar  (EXP)
N-methyl-N-nitrosourea  (EXP)
N-nitrosodiethylamine  (EXP,ISO)
N-nitrosodimethylamine  (EXP)
natamycin  (ISO)
nickel atom  (ISO)
nickel dichloride  (EXP)
nickel sulfate  (ISO)
nitrofen  (EXP)
nystatin  (ISO)
ochratoxin A  (EXP)
Ondansetron  (ISO)
ozone  (ISO)
palmitoyl ethanolamide  (EXP)
paracetamol  (EXP,ISO)
paraquat  (ISO)
perfluorononanoic acid  (ISO)
perfluorooctane-1-sulfonic acid  (EXP,ISO)
phenobarbital  (ISO)
PhIP  (EXP)
pirinixic acid  (ISO)
potassium bromate  (ISO)
prednisolone  (ISO)
pregnenolone 16alpha-carbonitrile  (ISO)
progesterone  (ISO)
propanal  (ISO)
propiconazole  (ISO)
protein kinase inhibitor  (ISO)
quartz  (EXP)
rac-lactic acid  (ISO)
raloxifene  (ISO)
resveratrol  (EXP,ISO)
Rhynchophylline  (ISO)
ritodrine  (ISO)
rotenone  (ISO)
S-butyl-DL-homocysteine (S,R)-sulfoximine  (EXP,ISO)
senecionine  (ISO)
serpentine asbestos  (ISO)
sevoflurane  (ISO)
silicon dioxide  (EXP,ISO)
sirolimus  (EXP)
sodium arsenate  (ISO)
sodium arsenite  (EXP,ISO)
sodium dichromate  (EXP)
sodium dodecyl sulfate  (ISO)
Soman  (EXP)
streptozocin  (EXP,ISO)
succimer  (ISO)
tacrolimus hydrate  (EXP,ISO)
tamoxifen  (ISO)
tert-butyl hydroperoxide  (ISO)
testosterone  (EXP)
tetrachloromethane  (EXP,ISO)
thapsigargin  (ISO)
thioacetamide  (EXP)
titanium dioxide  (EXP,ISO)
trichloroethene  (EXP,ISO)
trimethyltin  (ISO)
triptonide  (ISO)
troglitazone  (EXP)
tungsten  (ISO)
tunicamycin  (ISO)
valproic acid  (ISO)
vancomycin  (EXP)
vanillin  (EXP)
vildagliptin  (EXP)
vinclozolin  (EXP)
xylazine  (ISO)
zoledronic acid  (ISO)
zomepirac  (ISO)

Gene Ontology Annotations     Click to see Annotation Detail View

Biological Process
acute-phase response  (IEP)
cellular response to amyloid-beta  (IEP)
cellular response to hydrogen peroxide  (IDA)
cellular response to increased oxygen levels  (IEP)
cellular response to interleukin-1  (IEP)
cellular response to interleukin-6  (IEP)
cellular response to lipopolysaccharide  (IEP)
cellular response to nerve growth factor stimulus  (IEP)
cellular response to nutrient levels  (IEP)
cellular response to oxygen-glucose deprivation  (IEP)
cellular response to tumor necrosis factor  (IEP)
cellular response to X-ray  (IEP)
defense response to bacterium  (ISO,ISS)
extrinsic apoptotic signaling pathway in absence of ligand  (ISO)
innate immune response  (ISO,ISS)
long-term memory  (IMP)
negative regulation of hippocampal neuron apoptotic process  (IMP)
positive regulation of apoptotic process  (IGI)
positive regulation of cell projection organization  (IDA)
positive regulation of cold-induced thermogenesis  (ISO,ISS)
positive regulation of endothelial cell migration  (IDA)
positive regulation of endothelial tube morphogenesis  (IDA)
positive regulation of gene expression  (IDA)
positive regulation of iron ion import across plasma membrane  (IDA)
positive regulation of neuron apoptotic process  (IMP)
positive regulation of neuron death  (IDA)
positive regulation of reactive oxygen species biosynthetic process  (IDA)
positive regulation of reactive oxygen species metabolic process  (IMP)
response to bacterium  (IEP,ISO)
response to blue light  (IEP)
response to fructose  (IEP)
response to herbicide  (IDA)
response to iron(II) ion  (IEP)
response to mycotoxin  (IEP)
response to nutrient levels  (IEP)
response to oxidative stress  (IEP)
response to toxic substance  (IEP)
response to virus  (ISO)
response to xenobiotic stimulus  (IEP,IMP)
sequestering of iron ion  (ISO,ISS)
short-term memory  (IMP)
siderophore transport  (ISO,ISS)

Cellular Component

Molecular Function

References

References - curated
# Reference Title Reference Citation
1. Urinary NGAL and KIM-1: biomarkers for assessment of acute ischemic kidney injury following nephron sparing surgery. Abassi Z, etal., J Urol. 2013 Apr;189(4):1559-66. doi: 10.1016/j.juro.2012.10.029. Epub 2012 Oct 22.
2. Neutrophil gelatinase-associated lipocalin (NGAL/Lcn2) is upregulated in gastric mucosa infected with Helicobacter pylori. Alpízar-Alpízar W, etal., Virchows Arch. 2009 Sep;455(3):225-33. doi: 10.1007/s00428-009-0825-8.
3. Early urinary and plasma biomarkers for experimental diabetic nephropathy. Alter ML, etal., Clin Lab. 2012;58(7-8):659-71.
4. Diet high in fructose leads to an overexpression of lipocalin-2 in rat fatty liver. Alwahsh SM, etal., World J Gastroenterol. 2014 Feb 21;20(7):1807-21. doi: 10.3748/wjg.v20.i7.1807.
5. Fructose induces tubulointerstitial injury in the kidney of mice. Aoyama M, etal., Biochem Biophys Res Commun. 2012 Mar 9;419(2):244-9. doi: 10.1016/j.bbrc.2012.02.001. Epub 2012 Feb 8.
6. Neutrophil gelatinase-associated lipocalin and interleukin-10 regulate intramacrophage Chlamydia pneumoniae replication by modulating intracellular iron homeostasis. Bellmann-Weiler R, etal., Immunobiology. 2013 Jul;218(7):969-78. doi: 10.1016/j.imbio.2012.11.004. Epub 2012 Nov 21.
7. Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Berger T, etal., Proc Natl Acad Sci U S A. 2006 Feb 7;103(6):1834-9. doi: 10.1073/pnas.0510847103. Epub 2006 Jan 30.
8. Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study. Bhavsar NA, etal., Am J Kidney Dis. 2012 Aug;60(2):233-40. doi: 10.1053/j.ajkd.2012.02.336. Epub 2012 Apr 28.
9. Reactive astrocytes secrete lcn2 to promote neuron death. Bi F, etal., Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):4069-74. doi: 10.1073/pnas.1218497110. Epub 2013 Feb 19.
10. Long-term administration of aspirin inhibits tumour formation and triggers anti-neoplastic molecular changes in a pre-clinical model of colon carcinogenesis. Bousserouel S, etal., Oncol Rep. 2010 Feb;23(2):511-7.
11. Induction of neutrophil gelatinase-associated lipocalin in vascular injury via activation of nuclear factor-kappaB. Bu DX, etal., Am J Pathol. 2006 Dec;169(6):2245-53.
12. The primary structure of rat alpha 2 mu globulin-related protein. Chan YL, etal., Nucleic Acids Res 1988 Dec 9;16(23):11368.
13. Lipocalin 2 is required for pulmonary host defense against Klebsiella infection. Chan YR, etal., J Immunol. 2009 Apr 15;182(8):4947-56. doi: 10.4049/jimmunol.0803282.
14. Expression and localisation of brain-type organic cation transporter (BOCT/24p3R/LCN2R) in the normal rat hippocampus and after kainate-induced excitotoxicity. Chia WJ, etal., Neurochem Int. 2015 Aug;87:43-59. doi: 10.1016/j.neuint.2015.04.009. Epub 2015 May 21.
15. Chemopreventive and chemotherapeutic effect of dietary supplementation of vitamin D on cholangiocarcinoma in a Chemical-Induced animal model. Chiang KC, etal., Oncotarget. 2014 Jun 15;5(11):3849-61. doi: 10.18632/oncotarget.2000.
16. Lipocalin-2 Functions as Inhibitor of Innate Resistance to Mycobacterium tuberculosis. Dahl SL, etal., Front Immunol. 2018 Nov 26;9:2717. doi: 10.3389/fimmu.2018.02717. eCollection 2018.
17. The gonadal expression pattern of lipocalin‑2 and 24p3 receptor is modified in the gonads of the offspring of obese rats. De La Chesnaye E, etal., Mol Med Rep. 2020 Aug;22(2):1409-1419. doi: 10.3892/mmr.2020.11226. Epub 2020 Jun 12.
18. Lipocalin-2/Neutrophil Gelatinase-B Associated Lipocalin is Strongly Induced in Hearts of Rats With Autoimmune Myocarditis and in Human Myocarditis. Ding L, etal., Circ J. 2010 Jan 7.
19. Role of iron in brain lipocalin 2 upregulation after intracerebral hemorrhage in rats. Dong M, etal., Brain Res. 2013 Apr 10;1505:86-92. doi: 10.1016/j.brainres.2013.02.008. Epub 2013 Feb 15.
20. Lipocalin 2 and Blood-Brain Barrier Disruption in White Matter after Experimental Subarachnoid Hemorrhage. Egashira Y, etal., Acta Neurochir Suppl. 2016;121:131-4. doi: 10.1007/978-3-319-18497-5_23.
21. Chronic renovascular hypertension is associated with elevated levels of neutrophil gelatinase-associated lipocalin. Eirin A, etal., Nephrol Dial Transplant. 2012 Nov;27(11):4153-61. doi: 10.1093/ndt/gfs370. Epub 2012 Aug 23.
22. Novel urinary biomarkers and the early detection of acute kidney injury after open cardiac surgeries. Elmedany SM, etal., J Crit Care. 2017 Aug;40:171-177. doi: 10.1016/j.jcrc.2017.03.029. Epub 2017 Apr 6.
23. Interleukin-17-induced protein lipocalin 2 is dispensable for immunity to oral candidiasis. Ferreira MC, etal., Infect Immun. 2014 Mar;82(3):1030-5. doi: 10.1128/IAI.01389-13. Epub 2013 Dec 16.
24. Inflammation Profiling of Critically Ill Coronavirus Disease 2019 Patients. Fraser DD, etal., Crit Care Explor. 2020 Jun 22;2(6):e0144. doi: 10.1097/CCE.0000000000000144. eCollection 2020 Jun.
25. Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration. Fu WJ, etal., Diabetes Res Clin Pract. 2012 Jan;95(1):105-9. doi: 10.1016/j.diabres.2011.09.031. Epub 2011 Oct 20.
26. Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
27. Expression of acute-phase response proteins in retinal Muller cells in diabetes. Gerhardinger C, etal., Invest Ophthalmol Vis Sci. 2005 Jan;46(1):349-57.
28. Rat ISS GO annotations from GOA human gene data--August 2006 GOA data from the GO Consortium
29. Lipocalin-2 deficiency impairs thermogenesis and potentiates diet-induced insulin resistance in mice. Guo H, etal., Diabetes. 2010 Jun;59(6):1376-85. doi: 10.2337/db09-1735. Epub 2010 Mar 23.
30. Increased urinary neutrophil gelatinase associated lipocalin levels in a rat model of upper urinary tract infection. Ichino M, etal., J Urol. 2009 May;181(5):2326-31. Epub 2009 Mar 19.
31. Lipocalin 2 in the central nervous system host response to systemic lipopolysaccharide administration. Ip JP, etal., J Neuroinflammation. 2011 Sep 26;8:124. doi: 10.1186/1742-2094-8-124.
32. The lipocalin 24p3, which is an essential molecule in IL-3 withdrawal-induced apoptosis, is not involved in the G-CSF withdrawal-induced apoptosis. Kamezaki K, etal., Eur J Haematol 2003 Dec;71(6):412-7.
33. Nerve growth factor increases MMP9 activity in annulus fibrosus cells by upregulating lipocalin 2 expression. Kao TH, etal., Eur Spine J. 2015 Sep;24(9):1959-68. doi: 10.1007/s00586-014-3675-2. Epub 2014 Nov 21.
34. Microarray reveals complement components are regulated in the serum-deprived rat retinal ganglion cell line. Khalyfa A, etal., Mol Vis. 2007 Feb 28;13:293-308.
35. Transcriptional analysis of kidneys during repair from AKI reveals possible roles for NGAL and KIM-1 as biomarkers of AKI-to-CKD transition. Ko GJ, etal., Am J Physiol Renal Physiol. 2010 Jun;298(6):F1472-83. doi: 10.1152/ajprenal.00619.2009. Epub 2010 Feb 24.
36. Lipocalin-2 is an autocrine mediator of reactive astrocytosis. Lee S, etal., J Neurosci. 2009 Jan 7;29(1):234-49.
37. Hepatocytes and neutrophils cooperatively suppress bacterial infection by differentially regulating lipocalin-2 and neutrophil extracellular traps. Li H, etal., Hepatology. 2018 Oct;68(4):1604-1620. doi: 10.1002/hep.29919. Epub 2018 May 10.
38. Urinary Biomarkers in Relapsing Antineutrophil Cytoplasmic Antibody-associated Vasculitis. Lieberthal JG, etal., J Rheumatol. 2013 May;40(5):674-683. Epub 2013 Apr 1.
39. Downregulation of lipocalin-2 and Bim expression after remote limb preconditioning in the ischemic rat brain. Liu M, etal., Brain Res. 2018 Jan 15;1679:1-9. doi: 10.1016/j.brainres.2017.11.003. Epub 2017 Nov 6.
40. Enhanced apoptosis and decreased ampa receptors are involved in deficit in fear memory in rin1 knockout rats. Ma L, etal., J Affect Disord. 2020 May 1;268:173-182. doi: 10.1016/j.jad.2020.02.040. Epub 2020 Feb 27.
41. Lipocalin 2 modulates the cellular response to amyloid beta. Mesquita SD, etal., Cell Death Differ. 2014 Oct;21(10):1588-99. doi: 10.1038/cdd.2014.68. Epub 2014 May 23.
42. Rat ISS GO annotations from MGI mouse gene data--August 2006 MGD data from the GO Consortium
43. Metabolic endotoxemia and saturated fat contribute to circulating NGAL concentrations in subjects with insulin resistance. Moreno-Navarrete JM, etal., Int J Obes (Lond). 2010 Feb;34(2):240-9. doi: 10.1038/ijo.2009.242. Epub 2009 Dec 1.
44. Deletion of phospholipase A2 group IVc induces apoptosis in rat mammary tumour cells by the nuclear factor-κB/lipocalin 2 pathway. Nanashima N, etal., Biochem J. 2015 Jul 15;469(2):315-24. doi: 10.1042/BJ20150064. Epub 2015 May 27.
45. Electronic Transfer of LocusLink and RefSeq Data NCBI rat LocusLink and RefSeq merged data July 26, 2002
46. Bacterial colonization of nasal mucosa induces expression of siderocalin, an iron-sequestering component of innate immunity. Nelson AL, etal., Cell Microbiol. 2005 Oct;7(10):1404-17. doi: 10.1111/j.1462-5822.2005.00566.x.
47. The bacteriostatic protein lipocalin 2 is induced in the central nervous system of mice with west Nile virus encephalitis. Noçon AL, etal., J Virol. 2014 Jan;88(1):679-89. doi: 10.1128/JVI.02094-13. Epub 2013 Oct 30.
48. Bilirubin attenuates the renal tubular injury by inhibition of oxidative stress and apoptosis. Oh SW, etal., BMC Nephrol. 2013 May 17;14(1):105.
49. The effects of obesity and polycystic ovary syndrome on serum lipocalin-2 levels: a cross-sectional study. Panidis D, etal., Reprod Biol Endocrinol. 2010 Dec 9;8:151. doi: 10.1186/1477-7827-8-151.
50. α-Intercalated cells defend the urinary system from bacterial infection. Paragas N, etal., J Clin Invest. 2014 Jul;124(7):2963-76. doi: 10.1172/JCI71630. Epub 2014 Jun 17.
51. Evaluation of urine biomarkers of kidney injury in polycystic kidney disease. Parikh CR, etal., Kidney Int. 2012 Apr;81(8):784-90. doi: 10.1038/ki.2011.465. Epub 2012 Jan 18.
52. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy. Peters HP, etal., Nephrol Dial Transplant. 2011 Nov;26(11):3581-8. doi: 10.1093/ndt/gfr135. Epub 2011 Apr 5.
53. Cardiotrophin-1 administration prevents the renal toxicity of iodinated contrast media in rats. Quiros Y, etal., Toxicol Sci. 2013 Apr;132(2):493-501. doi: 10.1093/toxsci/kft007. Epub 2013 Jan 18.
54. Evaluation of putative biomarkers of nephrotoxicity after exposure to ochratoxin a in vivo and in vitro. Rached E, etal., Toxicol Sci. 2008 Jun;103(2):371-81. Epub 2008 Feb 27.
55. GOA pipeline RGD automated data pipeline
56. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
57. Kidney injury biomarkers in hypertensive, diabetic, and nephropathy rat models treated with contrast media. Rouse RL, etal., Toxicol Pathol. 2013;41(4):662-80. doi: 10.1177/0192623312464122. Epub 2012 Oct 19.
58. Time-dependent hemeoxygenase-1, lipocalin-2 and ferritin induction after non-contusion traumatic brain injury. Russell NH, etal., Brain Res. 2019 Dec 15;1725:146466. doi: 10.1016/j.brainres.2019.146466. Epub 2019 Sep 17.
59. Lipocalin 2-dependent inhibition of mycobacterial growth in alveolar epithelium. Saiga H, etal., J Immunol. 2008 Dec 15;181(12):8521-7. doi: 10.4049/jimmunol.181.12.8521.
60. Calprotectin and neutrophil gelatinase-associated lipocalin in the differentiation of pre-renal and intrinsic acute kidney injury. Seibert FS, etal., Acta Physiol (Oxf). 2013 Apr;207(4):700-8. doi: 10.1111/apha.12064. Epub 2013 Feb 14.
61. Acute phase response, inflammation and metabolic syndrome biomarkers of Libby asbestos exposure. Shannahan JH, etal., Toxicol Appl Pharmacol. 2012 Apr 15;260(2):105-14. doi: 10.1016/j.taap.2012.02.006. Epub 2012 Feb 16.
62. Phosphodiesterase-5 inhibition attenuates early renal ischemia-reperfusion-induced acute kidney injury: assessment by quantitative measurement of urinary NGAL and KIM-1. Sohotnik R, etal., Am J Physiol Renal Physiol. 2013 Apr 15;304(8):F1099-104. doi: 10.1152/ajprenal.00649.2012. Epub 2013 Jan 30.
63. Lipocalin 2 deficiency dysregulates iron homeostasis and exacerbates endotoxin-induced sepsis. Srinivasan G, etal., J Immunol. 2012 Aug 15;189(4):1911-9. doi: 10.4049/jimmunol.1200892. Epub 2012 Jul 11.
64. Lipocalin 2 imparts selective pressure on bacterial growth in the bladder and is elevated in women with urinary tract infection. Steigedal M, etal., J Immunol. 2014 Dec 15;193(12):6081-9. doi: 10.4049/jimmunol.1401528. Epub 2014 Nov 14.
65. Serum Lipocalin2 is a potential biomarker of liver irradiation damage. Sultan S, etal., Liver Int. 2013 Mar;33(3):459-68. doi: 10.1111/liv.12073. Epub 2013 Jan 18.
66. LIPOCALIN-2 is a major acute-phase protein in a rat and mouse model of sterile abscess. Sultan S, etal., Shock. 2012 Feb;37(2):191-6. doi: 10.1097/SHK.0b013e31823918c2.
67. Lipocalin-2 (NGAL) Attenuates Autophagy to Exacerbate Cardiac Apoptosis Induced by Myocardial Ischemia. Sung HK, etal., J Cell Physiol. 2017 Aug;232(8):2125-2134. doi: 10.1002/jcp.25672. Epub 2017 Mar 24.
68. Lipocalin 2 Suppresses Ocular Inflammation by Inhibiting the Activation of NF-κβ Pathway in Endotoxin-Induced Uveitis. Tang W, etal., Cell Physiol Biochem. 2018;46(1):375-388. doi: 10.1159/000488472. Epub 2018 Mar 23.
69. Light-Induced Lipocalin 2 Facilitates Cellular Apoptosis by Positively Regulating Reactive Oxygen Species/Bim Signaling in Retinal Degeneration. Tang W, etal., Invest Ophthalmol Vis Sci. 2018 Dec 3;59(15):6014-6025. doi: 10.1167/iovs.18-25213.
70. Tentative Sequence Identification Numbers Tentative Sequence Data IDs. TIGR Gene Index, Rat Data
71. Urine NGAL and KIM-1 in children and adolescents with hyperuricemia. Tomczak J, etal., Pediatr Nephrol. 2013 May 15.
72. Atorvastatin restores endothelial function in offspring of protein-restricted rats in a cholesterol-independent manner. Torrens C, etal., Hypertension. 2009 Apr;53(4):661-7. Epub 2009 Feb 16.
73. Lipocalin 2 as a new biomarker for fetal lung hypoplasia in congenital diaphragmatic hernia. Tsuda H, etal., Clin Chim Acta. 2016 Nov 1;462:71-76. doi: 10.1016/j.cca.2016.08.023. Epub 2016 Aug 31.
74. Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. Viau A, etal., J Clin Invest. 2010 Nov;120(11):4065-76. doi: 10.1172/JCI42004.
75. Up-regulated lipocalin-2 in pulmonary hypertension involving in pulmonary artery SMC resistance to apoptosis. Wang G, etal., Int J Biol Sci. 2014 Jul 17;10(7):798-806. doi: 10.7150/ijbs.9470. eCollection 2014.
76. Genome-wide transcriptome profiling of region-specific vulnerability to oxidative stress in the hippocampus. Wang X, etal., Genomics. 2007 Aug;90(2):201-12. Epub 2007 Jun 5.
77. KIM-1 and NGAL: new markers of obstructive nephropathy. Wasilewska A, etal., Pediatr Nephrol. 2011 Apr;26(4):579-86. doi: 10.1007/s00467-011-1773-5. Epub 2011 Jan 31.
78. Lipocalin-2 is expressed by activated granulocytes and keratinocytes in affected skin and reflects disease activity in acne inversa/hidradenitis suppurativa. Wolk K, etal., Br J Dermatol. 2017 Nov;177(5):1385-1393. doi: 10.1111/bjd.15424. Epub 2017 Sep 19.
79. Lipocalin 2 is protective against E. coli pneumonia. Wu H, etal., Respir Res. 2010 Jul 15;11:96. doi: 10.1186/1465-9921-11-96.
80. Lipocalin-2 enhances angiogenesis in rat brain endothelial cells via reactive oxygen species and iron-dependent mechanisms. Wu L, etal., J Neurochem. 2015 Mar;132(6):622-8. doi: 10.1111/jnc.13023. Epub 2015 Jan 29.
81. Combined biomarkers evaluation for diagnosing kidney injury in preeclampsia. Xiao J, etal., Hypertens Pregnancy. 2013 Nov;32(4):439-49. doi: 10.3109/10641955.2013.827203. Epub 2013 Aug 19.
82. Neuronal production of lipocalin-2 as a help-me signal for glial activation. Xing C, etal., Stroke. 2014 Jul;45(7):2085-92. doi: 10.1161/STROKEAHA.114.005733. Epub 2014 Jun 10.
83. Liver is the major source of elevated serum lipocalin-2 levels after bacterial infection or partial hepatectomy: a critical role for IL-6/STAT3. Xu MJ, etal., Hepatology. 2015 Feb;61(2):692-702. doi: 10.1002/hep.27447.
84. Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure. Yndestad A, etal., Eur Heart J. 2009 May;30(10):1229-36. Epub 2009 Mar 26.
85. The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages. Zhang J, etal., Mol Endocrinol. 2008 Jun;22(6):1416-26. Epub 2008 Feb 21.
86. Down-regulation of lipocalin 2 contributes to chemoresistance in glioblastoma cells. Zheng LT, etal., J Neurochem. 2009 Dec;111(5):1238-51. Epub 2009 Oct 5.
Additional References at PubMed
PMID:2542864   PMID:12477932   PMID:16377569   PMID:16502470   PMID:16546827   PMID:17490638   PMID:19056867   PMID:20550936   PMID:21457438   PMID:21551085   PMID:22117066   PMID:22278021  
PMID:22349381   PMID:22664934   PMID:22833177   PMID:22889806   PMID:23012479   PMID:23158800   PMID:23360846   PMID:23376485   PMID:23481292   PMID:23533145   PMID:23940770   PMID:24006456  
PMID:24374540   PMID:24816434   PMID:25062286   PMID:25087119   PMID:25148248   PMID:25645918   PMID:25782996   PMID:26463963   PMID:27026710   PMID:27068509   PMID:27087673   PMID:27233602  
PMID:27756197   PMID:27780864   PMID:27865916   PMID:29367586   PMID:29378951   PMID:29402223   PMID:29704511   PMID:29845768   PMID:29980183   PMID:30087458   PMID:30367561   PMID:30404645  
PMID:30871254   PMID:31269059   PMID:31327865   PMID:31480394   PMID:32412814   PMID:32630021   PMID:32845875   PMID:33319934   PMID:33510115  


Genomics

Comparative Map Data
Lcn2
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
mRatBN7.2315,680,688 - 15,684,033 (-)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl315,680,687 - 15,684,095 (-)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx318,749,510 - 18,752,856 (-)NCBIRnor_SHR
UTH_Rnor_SHRSP_BbbUtx_1.0327,334,505 - 27,337,851 (-)NCBIRnor_SHRSP
UTH_Rnor_WKY_Bbb_1.0325,585,359 - 25,588,705 (-)NCBIRnor_WKY
Rnor_6.0311,414,189 - 11,417,534 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl311,414,186 - 11,417,546 (-)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.0316,763,059 - 16,766,404 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.4311,511,402 - 11,514,747 (-)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.1311,407,773 - 11,411,119 (-)NCBI
Celera310,423,569 - 10,426,914 (-)NCBICelera
Cytogenetic Map3p12NCBI
LCN2
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh389128,149,453 - 128,153,453 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p13 Ensembl9128,149,071 - 128,153,453 (+)EnsemblGRCh38hg38GRCh38
GRCh379130,911,732 - 130,915,732 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 369129,951,553 - 129,955,555 (+)NCBINCBI36Build 36hg18NCBI36
Build 349127,991,271 - 127,995,288NCBI
Celera9101,562,624 - 101,566,626 (+)NCBICelera
Cytogenetic Map9q34.11NCBI
HuRef9100,525,402 - 100,529,404 (+)NCBIHuRef
CHM1_19131,062,742 - 131,066,744 (+)NCBICHM1_1
T2T-CHM13v2.09140,356,542 - 140,360,542 (+)NCBIT2T-CHM13v2.0
Lcn2
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm39232,274,649 - 32,277,751 (-)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl232,274,645 - 32,278,264 (-)EnsemblGRCm39 Ensembl
GRCm38232,384,637 - 32,387,739 (-)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl232,384,633 - 32,388,252 (-)EnsemblGRCm38mm10GRCm38
MGSCv37232,240,157 - 32,243,259 (-)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv36232,206,646 - 32,209,748 (-)NCBIMGSCv36mm8
Celera232,090,046 - 32,093,150 (-)NCBICelera
Cytogenetic Map2BNCBI
cM Map222.09NCBI
LCN2
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
PanPan1.19127,940,799 - 127,944,798 (+)NCBIpanpan1.1PanPan1.1panPan2
PanPan1.1 Ensembl9127,940,799 - 127,944,798 (+)Ensemblpanpan1.1panPan2
Mhudiblu_PPA_v0999,259,278 - 99,274,494 (+)NCBIMhudiblu_PPA_v0Mhudiblu_PPA_v0panPan3
LCN2
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
CanFam3.1955,328,118 - 55,342,535 (-)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl955,328,133 - 55,332,038 (-)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha954,522,898 - 54,537,231 (-)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.0956,250,316 - 56,264,670 (-)NCBIROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl956,250,331 - 56,254,237 (-)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1955,010,191 - 55,024,522 (-)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.0955,324,906 - 55,339,237 (-)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0955,416,588 - 55,430,934 (-)NCBIUU_Cfam_GSD_1.0
Lcn2
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HiC_Itri_2NW_024404947195,953,204 - 195,956,869 (+)NCBIHiC_Itri_2
SpeTri2.0 EnsemblNW_00493648715,721,684 - 15,728,221 (+)EnsemblSpeTri2.0
SpeTri2.0NW_00493648715,721,752 - 15,725,396 (+)NCBISpeTri2.0SpeTri2.0SpeTri2.0
LCN2
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Sscrofa11.1 Ensembl1268,609,887 - 268,614,644 (+)EnsemblSscrofa11.1susScr11Sscrofa11.1
Sscrofa11.11268,609,975 - 268,614,651 (+)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.21302,600,679 - 302,609,836 (+)NCBISscrofa10.2Sscrofa10.2susScr3
LCN2
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChlSab1.1129,976,278 - 9,981,087 (-)NCBIChlSab1.1ChlSab1.1chlSab2
ChlSab1.1 Ensembl129,976,614 - 9,980,870 (-)EnsemblChlSab1.1ChlSab1.1 EnsemblchlSab2
Vero_WHO_p1.0NW_0236660796,251,600 - 6,256,754 (+)NCBIVero_WHO_p1.0Vero_WHO_p1.0

Variants

.
Variants in Lcn2
27 total Variants
miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:139
Count of miRNA genes:98
Interacting mature miRNAs:103
Transcripts:ENSRNOT00000018776
Prediction methods:Microtar, Miranda, Rnahybrid, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.


QTLs in Region (mRatBN7.2)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
70202Alc19Alcohol consumption QTL 192.5drinking behavior trait (VT:0001422)ethanol intake volume to total fluid intake volume ratio (CMO:0001591)3127494778Rat
631679Cm10Cardiac mass QTL 107.340.0001heart left ventricle mass (VT:0007031)heart left ventricle weight to body weight ratio (CMO:0000530)3131158234Rat
631831Alc8Alcohol consumption QTL 82.7consumption behavior trait (VT:0002069)calculated ethanol drink intake rate (CMO:0001615)3133230976Rat
61468Bp15Blood pressure QTL 154.4blood pressure trait (VT:0000183)diastolic blood pressure (CMO:0000005)3133278763Rat
61468Bp15Blood pressure QTL 154.4blood pressure trait (VT:0000183)systolic blood pressure (CMO:0000004)3133278763Rat
61468Bp15Blood pressure QTL 154.4blood pressure trait (VT:0000183)pulse pressure (CMO:0000292)3133278763Rat
631545Bp85Blood pressure QTL 853.1arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)3133278763Rat
4889966Bss95Bone structure and strength QTL 954.4tibia area (VT:1000281)tibia-fibula cross-sectional area (CMO:0001718)3136847613Rat
2312664Scl62Serum cholesterol level QTL 620.05blood cholesterol amount (VT:0000180)serum total cholesterol level (CMO:0000363)3138710544Rat
631568Bp92Blood pressure QTL 922.20.005arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)3139874793Rat
2290452Scl56Serum cholesterol level QTL 562.26blood cholesterol amount (VT:0000180)plasma total cholesterol level (CMO:0000585)3191609953Rat
1298526Arunc3Aerobic running capacity QTL 32.2exercise endurance trait (VT:0002332)maximum distance run on treadmill (CMO:0001406)3822719433703538Rat
10401810Kidm53Kidney mass QTL 53kidney mass (VT:0002707)both kidneys wet weight to body weight ratio (CMO:0000340)3822719447233430Rat
70203Gcr2Gastric cancer resistance QTL 22.6stomach morphology trait (VT:0000470)stomach tumor susceptibility score (CMO:0002043)3865816227494778Rat
1358357Srcrtb1Stress Responsive Cort Basal QTL 16.360.002blood corticosterone amount (VT:0005345)plasma corticosterone level (CMO:0001173)3865816227494778Rat
6893355Bw101Body weight QTL 1010.40.38body mass (VT:0001259)body weight (CMO:0000012)31077870430357018Rat
6893363Bw105Body weight QTL 1052.60.0036body mass (VT:0001259)body weight (CMO:0000012)31077870430357018Rat
1558654Bw56Body weight QTL 564.50.0000171body mass (VT:0001259)body weight (CMO:0000012)31077870430357018Rat
70191BpQTLcluster4Blood pressure QTL cluster 43arterial blood pressure trait (VT:2000000)absolute change in mean arterial blood pressure (CMO:0000533)31077870450302886Rat
70191BpQTLcluster4Blood pressure QTL cluster 43arterial blood pressure trait (VT:2000000)absolute change in systolic blood pressure (CMO:0000607)31077870450302886Rat
1558647Cm46Cardiac mass QTL 465.40.0000055heart mass (VT:0007028)heart wet weight (CMO:0000069)31077882330356773Rat
1558650Cm48Cardiac mass QTL 4840.0001heart mass (VT:0007028)heart weight to body weight ratio (CMO:0000074)31077882330356773Rat
1558657Cm43Cardiac mass QTL 436.60.0000000293heart mass (VT:0007028)heart wet weight (CMO:0000069)31077882330356773Rat
1358905Hrtrt17Heart rate QTL 175.90.000014heart pumping trait (VT:2000009)heart rate (CMO:0000002)31086191289878372Rat
1358885Bp251Blood pressure QTL 2513.8arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)314489145121056321Rat
1358888Bp264Blood pressure QTL 2644.43arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)314489145121056321Rat
2298542Neuinf11Neuroinflammation QTL 113.9nervous system integrity trait (VT:0010566)spinal cord complement component 1, q subcomponent, B chain mRNA level (CMO:0002126)31500542276927699Rat

Markers in Region
AA946503  
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.2315,681,562 - 15,681,921 (+)MAPPERmRatBN7.2
Rnor_6.0311,415,064 - 11,415,422NCBIRnor6.0
Rnor_5.0316,763,934 - 16,764,292UniSTSRnor5.0
RGSC_v3.4311,512,277 - 11,512,635UniSTSRGSC3.4
Celera310,424,444 - 10,424,802UniSTS
RH 3.4 Map360.1UniSTS
Cytogenetic Map3p11UniSTS


Expression


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

alimentary part of gastrointestinal system circulatory system endocrine system exocrine system hemolymphoid system hepatobiliary system integumental system musculoskeletal system nervous system renal system reproductive system respiratory system appendage
High
Medium 13 15 15 15 14 27 4
Low 2 25 26 18 10 18 2 3 51 15 12 7 2
Below cutoff 5 16 8 8 8 6 8 23 5 2 6

Sequence


Reference Sequences
RefSeq Acc Id: ENSRNOT00000018776   ⟹   ENSRNOP00000018776
RefSeq Status:
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl315,680,689 - 15,684,095 (-)Ensembl
Rnor_6.0 Ensembl311,414,186 - 11,417,546 (-)Ensembl
RefSeq Acc Id: ENSRNOT00000094191   ⟹   ENSRNOP00000078583
RefSeq Status:
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl315,680,687 - 15,684,095 (-)Ensembl
RefSeq Acc Id: NM_130741   ⟹   NP_570097
RefSeq Status: PROVISIONAL
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2315,680,688 - 15,684,033 (-)NCBI
Rnor_6.0311,414,189 - 11,417,534 (-)NCBI
Rnor_5.0316,763,059 - 16,766,404 (-)NCBI
RGSC_v3.4311,511,402 - 11,514,747 (-)RGD
Celera310,423,569 - 10,426,914 (-)RGD
Sequence:
Reference Sequences
RefSeq Acc Id: NP_570097   ⟸   NM_130741
- Peptide Label: precursor
- UniProtKB: P30152 (UniProtKB/Swiss-Prot)
- Sequence:
RefSeq Acc Id: ENSRNOP00000018776   ⟸   ENSRNOT00000018776
RefSeq Acc Id: ENSRNOP00000078583   ⟸   ENSRNOT00000094191
Protein Domains
Lipocln_cytosolic_FA-bd_dom

Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-P30152-F1-model_v2 AlphaFold P30152 1-198 view protein structure

Transcriptome

eQTL   View at Phenogen
WGCNA   View at Phenogen
Tissue/Strain Expression   View at Phenogen

Promoters
RGD ID:13691985
Promoter ID:EPDNEW_R2510
Type:multiple initiation site
Name:Lcn2_1
Description:lipocalin 2
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Experiment Methods:Single-end sequencing.
Position:
Rat AssemblyChrPosition (strand)Source
Rnor_6.0311,417,542 - 11,417,602EPDNEW

Additional Information

Database Acc Id Source(s)
AGR Gene RGD:69408 AgrOrtholog
BioCyc Gene G2FUF-50141 BioCyc
Ensembl Genes ENSRNOG00000013973 Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Ensembl Protein ENSRNOP00000018776 ENTREZGENE, UniProtKB/Swiss-Prot
  ENSRNOP00000078583.1 UniProtKB/TrEMBL
Ensembl Transcript ENSRNOT00000018776 ENTREZGENE, UniProtKB/Swiss-Prot
  ENSRNOT00000094191.1 UniProtKB/TrEMBL
Gene3D-CATH 2.40.128.20 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
IMAGE_CLONE IMAGE:7310185 IMAGE-MGC_LOAD
InterPro Calycin UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  LCN2/LCN12 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Lipocalin UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Lipocln_cytosolic_FA-bd_dom UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
KEGG Report rno:170496 UniProtKB/Swiss-Prot
MGC_CLONE MGC:105339 IMAGE-MGC_LOAD
NCBI Gene 170496 ENTREZGENE
PANTHER PTHR11430 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Pfam Lipocalin UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
PharmGKB LCN2 RGD
PhenoGen Lcn2 PhenoGen
PRINTS NGELATINASE UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Superfamily-SCOP SSF50814 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
TIGR TC207006
UniProt A0A8I5ZNE2_RAT UniProtKB/TrEMBL
  NGAL_RAT UniProtKB/Swiss-Prot, ENTREZGENE
UniProt Secondary Q5HZF1 UniProtKB/Swiss-Prot


Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2002-06-10 Lcn2  lipocalin 2      Name updated 70584 APPROVED

RGD Curation Notes
Note Type Note Reference